| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 2.47B | — |
| Operating expense | — | — |
| Net income | 691.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ZTS returned -49.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -38.3% |
| 1 year | -49.8% |
| 5 years | -60.5% |
| 10 years | +63.3% |
| All-time high | $244.03 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ZTS would be worth today ›Yes. Zoetis Inc. paid 4 dividends over the past 12 months. The most recent was $0.53 per share on Jul 20, 2026. The dividend yield is 2.75%.
Zoetis Inc. stock trades on NYSE under the ticker symbol ZTS.
Zoetis Inc. is part of the Healthcare sector.
Zoetis Inc. has a market cap of 31.58B USD, based on the latest quote.
Zoetis Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
